We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TORONTO, July 10, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company”) announces that, in connection with its creditor protection proceedings under the Companies’...
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) and its subsidiaries were granted creditor protection...
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “Acerus”) were granted protection pursuant to...
Suspension de la négociation par l'OCRCVM - ASP Canada NewsWire TORONTO, le 26 janv. 2023 TORONTO, le 26 janv. 2023 /CNW/ - L'OCRCVM a suspendu la négociation des titres suivants...
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus...
IIROC Trading Halt - ASP Canada NewsWire TORONTO, Jan. 26, 2023 TORONTO, Jan. 26, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Acerus Pharmaceuticals Corporation TSX...
TORONTO, Dec. 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that Mr. Scott Leckie has resigned from the...
TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that it and its wholly-owned subsidiary, Acerus...
TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and...
TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has amended the promissory note (the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.36 | 0.36 | 0.36 | 0 | 0 | CS |
4 | 0 | 0 | 0.36 | 0.36 | 0.36 | 0 | 0 | CS |
12 | 0 | 0 | 0.36 | 0.36 | 0.36 | 0 | 0 | CS |
26 | 0 | 0 | 0.36 | 0.36 | 0.36 | 0 | 0 | CS |
52 | 0 | 0 | 0.36 | 0.36 | 0.36 | 0 | 0 | CS |
156 | 0.325 | 928.571428571 | 0.035 | 5.67 | 0.025 | 17354 | 0.06918553 | CS |
260 | 0.29 | 414.285714286 | 0.07 | 5.67 | 0.025 | 94093 | 0.05279402 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions